Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Topical Menthol Application in Chemotherapy-Related Peripheral Neuropathy in Patients With Breast Cancer

NCT05429814 is registered in ClinicalTrials.gov with Necmettin Erbakan University as lead sponsor.

NCT NCT05429814
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05429814 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Topical Menthol Application in Chemotherapy-Related Peripheral Neuropathy in Patients With Breast Cancer
Lead sponsor
Necmettin Erbakan University
Phase
Not applicable
Overall status
Completed
Start date
July 1, 2022
Completion date
April 1, 2023
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, chemotherapy effect, peripheral neuropathies